On May 30, 2013, Health Canada approved Xtandi for the treatment of patients with metastatic castration-resistant prostate cancer, or mCRPC, who have received prior docetaxel therapy (chemotherapy medication). The announcement was made today by Astellas Pharma Canada, Inc., the Canadian subsidiary of Tokyo-based Astellas Pharma, Inc.
Health Canada says three companies are voluntarily recalling all lots of the antipsychotic drug quetiapine. A Health Canada news release says it's due to potential contamination with the antibiotic product clindamycin during the manufacturing process.
PERJETA (pertuzumab), in combination with the current standard of care, HERCEPTIN® (trastuzumab) and docetaxel chemotherapy, is approved for the treatment of patients with HER2-positive metastatic breast cancer (mBC) who have not received prior anti-HER2 therapy or chemotherapy for metastatic disease.
Health Canada has come up with a temporary solution to eliminate a jurisdictional grey area that may have contributed to over 1,200 patients receiving diluted chemotherapy drugs. Officials with the federal health agency will discuss the proposal in a conference call Friday with top health bureaucrats from all the provinces and territories.
Health Canada is advising Canadians that Novartis Consumer Health Canada Inc. is conducting a voluntary recall of 17 products (see chart below) as the child resistant mechanism of the bottle cap can fail. As a result, children may be able to open the bottle and ingest the product. The ingredients of the affected products may be harmful to children.
Arbonne International Distribution Inc. is voluntarily recalling one lot (lot 043904) of its RE9 Advanced for Men Facial Moisturizer SPF 20 Sunscreen due to microbial contamination. Product testing undertaken by the company detected bacteria (Aerococcus viridans) that may pose serious...
New standard for hospitals on reporting adverse drug reactions released today - Standard will be supported by marketing activities to boost reporting by health professionalsJanuary 30, 2013 6:21 am | by Health Canada | News | Comments
The Honourable Leona Aglukkaq, Minister of Health, today congratulated Accreditation Canada on including, for the first time, guidance on the reporting of adverse drug reactions in its latest Medication Management Standards for health care facilities, including hospitals.
Health Canada is informing Canadians that Prestige Brands is conducting a voluntary recall of one lot (lot 3742) of its Infants Little Remedies for Fevers after testing conducted by the company indicated some bottles may contain less than the claimed amount of acetaminophen.
Health Canada is informing Canadians of a labelling update for all cholesterol-lowering drugs (also known as statins) regarding the risk of increased blood sugar levels and a small increased risk of diabetes among patients already at risk for the disease.
New Labelling Information for all Botulinum Toxin Products: Botox/Botox Cosmetic, Dysport, Xeomin/Xeomin Cosmetic and MyoblocJanuary 21, 2013 7:21 am | by Health Canada | News | Comments
In order to help prevent medication errors with the use of botulinum toxin products currently available on the Canadian market, Health Canada will be requesting that all manufacturers of these products revise their product labels to reflect that each product has its own individual potency...
Mould can develop between the removable seat cushion and the hard plastic frame of the sleeper. The advisory affects Model R6070, which was the only model sold in Canada. While mould is not present when the product is purchased, it can grow when the product remains wet or moist, or is...
Almost everyone makes New Year’s resolutions at some point in their lives. Many Canadians each year resolve to eat better and become more physically active. If these are among your goals for 2013, learning more about Canada’s Food Guide will help you and your family on your way to...
Four unauthorized natural health products have been removed from sale as they may pose serious risks to the health of Canadians. The "ExtenZe" products (shown below) are promoted as sexual enhancement products and contain ingredients that legally require they be sold with a prescription in Canada.
Pradaxa (dabigatran, previously called Pradax): not to be used in patients with artificial heart valvesDecember 21, 2012 3:20 pm | by Health Canada | News | Comments
Health Canada is advising health care professionals and the public that, based on new information, the blood-thinning drug Pradaxa is not to be used in patients with artificial heart valves (also known as prosthetic heart valves) due to the risk of strokes, bleeding, heart attacks, and...
Health Canada's testing of "EV Princess Express Peeling", "EV Princess Extra Whitening Night Cream" and "Ling Zhi BB Whitening Cream" identified levels of mercury that are beyond the allowable limit set by Health Canada. All three are unauthorized natural health products promoted as facial creams.
Harper Government Applauds One of the Largest Ever Public-Private Investments in Health Research - The Chagnon Family and the Azrieli Foundation commit $46 million to Support...December 21, 2012 9:21 am | by Health Canada | News | Comments
Today the Honourable Leona Aglukkaq, Minister of Health, and the Honourable Jim Flaherty, Minister of Finance, are pleased to congratulate the Chagnon Family and the Azrieli Foundation for partnering with Brain Canada and the Government of Canada, through the Canada Brain Research Fund,...
Further to our previous communications, Health Canada is advising Canadians that three additional unauthorized products promoted for weight loss have been seized from the "Cube Inc." store in Richmond, B.C.
Health Canada would like to remind all Canadians of some basic steps they can take to help reduce the risk of foodborne illness during the holiday season.
Federal Health Minister Leona Aglukkaq, British Columbia Health Minister Margaret MacDiarmid, and Grand Chief Doug Kelly, Chair of the BC First Nations Health Council signed a Health Partnership Accord today re-affirming their long-term commitment and shared vision for a better, more...
Harper Government Announces Proposed New Marihuana for Medical Purposes Regulations - Changes improve public safety, maintain patient accessDecember 16, 2012 12:21 pm | by Health Canada | News | Comments
The Honourable Leona Aglukkaq, Minister of Health, announced today that after a broad consultation process, the Government of Canada intends to make changes to the way Canadians access marihuana for medical purposes.
Health Canada and U.S. Food and Drug Administration complete first joint review of veterinary drug productDecember 14, 2012 6:21 am | by Health Canada | News | Comments
Health Canada and the U.S. Food and Drug Administration's Center for Veterinary Medicine today announced the first simultaneous review and approval of a veterinary drug application under an initiative to better align the approval process for these products.
If a personal listening device is on your shopping list this holiday season, Health Canada reminds you that high noise levels can impact your hearing health and physical safety. Personal listening devices can include iPods, MP3 players, portable radios, cellular phones and gaming headsets.
On December 3, 2012, Health Canada suspended the Establishment Licence of Mississauga, Ontario-based testing facility Chemi Pharmaceutical Inc. after finding falsified test results during an inspection.
Health Canada has suspended the Establishment Licence of Chemi Pharmaceutical Inc. of Mississauga, Ont., after uncovering falsified testing results during the course of an inspection.